Hercules Capital

Venture debt for innovators

San Mateo, CA, United States

Other Business & Investment Investment & CapitalPublic

Hercules Capital is a specialty finance company that provides senior secured venture growth loans (venture debt) to high-growth technology and life sciences companies. Founded in 2003 and publicly traded since 2005, it has committed over $25 billion to more than 700 companies, offering non-dilutive financing solutions from $10 million to $200 million.

Shareable draft

Check out Hercules Capital on @MedStartr Today Hercules Capital is a specialty finance company that provides senior secured venture growth loans (venture debt) to high-growth technology and life sciences companies. Founded in 2003 and publicly traded since 2005, it has committed over $25 billion to more than 700 companies, offering non-dilutive financing solutions from $10 million to $200 million. #GeneticallyDrivenNeuromuscularDiseases #SeriousAndRareDiseases #InflammatoryDiseases #HidradenitisSuppurativa #PsoriaticArthritis #SeriousHematologicDiseases #CancerOncology #Other #BusinessInvestmentProfessionalServices #InvestmentCapital #MedMo #MedStartrVentures

https://www.medstartr.ai/s/IzwiHInh0ok

Get Involved in Hercules Capital

How We Help

Problem Statement

High-growth, venture capital-backed companies, particularly in life sciences and healthcare, often require significant capital for development and expansion but may wish to avoid further equity dilution. Hercules Capital solves this by providing non-dilutive, senior secured venture growth loans.

Core Technology

Venture lending and financial expertise (note: not a technology company in the traditional sense)

Key Differentiators

Offers non-dilutive financing solutions, provides customizable and less dilutive financing to support long-term success, and complements existing equity capital.

Clinical Focus

Life sciences and healthcare, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, and healthcare technology.

Target Customers

High-growth, innovative, venture capital-backed companies, especially within the life sciences and healthcare industries.

Company Info

Business Model: Other
Founded: 2003
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: herculescapital.com

Disease Areas

Genetically Driven Neuromuscular Diseases Serious and Rare Diseases Inflammatory Diseases Hidradenitis Suppurativa Psoriatic Arthritis Serious Hematologic Diseases Cancer & Oncology

Technologies

Venture LendingSpecialty FinanceGrowth CapitalNon-Dilutive Financing

Clinical & IP

🔬

Clinical Validation

Portfolio includes FDA-regulated diagnostics, medical devices, therapeutics, and healthcare delivery companies at clinical validation stages.

🌐Website

MedStartr Engagement Score

Too Big!

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Hercules Capital?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.